Baby of brain-dead woman delivered in Georgia, woman's mother says

A brain-dead woman's baby has been delivered by caesarean section, the woman's mother says, after the hospital said her body had to be kept on life support due to abortion law in the US state of Georgia. Adriana Smith's baby, named Chance, was born prematurely on Friday, Ms Smith's mother told local TV station 11 Alive.The boy, who weighs 1lb 13oz (08kg), is being kept in the neonatal intensive care unit, said Ms Smith's mother, April Newkirk. "He's expected to be OK," she told the outlet, an affiliate of NBC News. "He's just fighting. We just want prayers for him."Ms Newkirk said her daughter, a 31-year-old nurse, would be taken off life support on Tuesday.
"It's hard to process," she said. "I'm her mother. I shouldn't be burying my daughter. My daughter should be burying me."The BBC has contacted the hospital for comment. It has previously declined to comment on individual cases, but has insisted that it prioritises "the safety and well-being of the patients we serve."Ms Smith went to a different hospital in February because of severe headaches, and was given a medication and sent home, her mother previously said. But the next day, Ms Smith woke up gasping for air. Emory University Hospital determined she had blood clots in her brain, and declared her brain-dead, her mother said. At that point, her baby's due date was over three months away. But her family said doctors at Emory told them they could not take her off life support or remove devices keeping her breathing because the state bans abortion after cardiac activity can be detected, around six weeks into pregnancy. Ms Newkirk said at the time that her grandson may be blind, unable to walk or even struggle to survive because of the complications of her daughter's health. The decision to keep her on life support "should have been left up to the family", Ms Newkirk told the same NBC affiliate in May. Georgia's Republican Governor Brian Kemp signed a near-total abortion ban in the state in 2019. But the law did not go into effect until after the US Supreme Court took the decision in 2022 to overturn the Roe v Wade ruling, which had guaranteed women the constitutional right to an abortion.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Daily Mail​

29 minutes ago

• Daily Mail​

ESPN star Jay Harris shares major update amid devastating cancer battle

SportsCenter host and popular ESPN anchor Jay Harris received good news after his recent prostate cancer surgery. 'My doctor said the surgery went really well – so well, in fact, that the cancer that was in my prostate stayed there,' the 60-year-old married father said in a self-shot social media video. 'Didn't spread to any surrounding areas. So when he took the prostate out, he took that with it. So it's all good. There are other details that I won't bore you with. The main thing is, we're all good and looking forward to July 12, getting back to SportsCenter, getting back to work. 'Just home, resting up, chilling,' he continued. 'Appreciate the prayers and the thoughts and the messages and the calls and the deliveries. Thank you so much. Appreciate all the love and I will holler.' Harris' t-shirt in the clip is emblazed with the image of wrestling legend Ric Flair, who recently revealed his second battle with skin cancer. Harris recently announced his prostate cancer diagnosis and his planned surgery on ABC's Good Morning America earlier this month. 'My doctor's quite optimistic, per my last scan, nothing has spread,' he told ABC host and former New York Giants star Michael Strahan. 'So, once we take out the prostate, hopefully that will be it. That's the goal.' So far, so good, as Harris revealed Monday. Harris told Strahan he came forward with his diagnosis to help other men, especially African Americans, see the signs of the disease and get themselves checked. 'Because we don't talk. I was at a golf trip with some buddies of mine and we were just sitting around talking about things that I probably can't talk about on television right now. And I mentioned the news to them, I told them what was going on with me. And then the conversation from there was fantastic,' Harris added. 'By not talking about them, I hate to be morbid, but we sentenced ourselves to death for not talking. They had no idea until I brought it up.' Harris also revealed that his dad had the same disease. The broadcaster also stated that men should take a cue from women and get regular health check-ups. Harris' frequent co-anchor Hannah Storm was diagnosed with an early form of breast cancer last year and has been checking in on her on-screen partner throughout the process. Fellow ESPNer and former Showtime boxing announcer Brian Custer has also been a help after undergoing a similar surgery, Harris said.

The Independent

an hour ago

• The Independent

Wegovy manufacturer ends deal with Hims & Hers to distribute weight loss drug

Novo Nordisk has announced it is ending its distribution collaboration with US telehealth firm Hims & Hers Health over the popular weight-loss drug, Wegovy. The Danish pharmaceutical giant and Hims & Hers had initially partnered in April, with plans for the telehealth company to offer Wegovy as part of a bundled package on its platform. Despite the halt, Hims & Hers stated earlier this month that it intends to continue selling "personalised" doses of Wegovy, priced from approximately $165 a month. This approach, according to Hims, is permissible under clinical guidelines, citing reasons such as reduced side effects. Hims also provides liraglutide, a generic version of an older Novo Nordisk diabetes medication known for its weight-loss effects, alongside branded Wegovy and Eli Lilly's competing drug, Zepbound. Wall Street analysts have questioned whether Hims' offerings actually qualify as "personalized" and say it is unclear if Novo, which has said mass production of copies is breaking the law, will allow it. Hims & Hers was not immediately available for a comment outside of the company's regular work hours. A U.S. federal judge on Friday rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's weight-loss drugs Ozempic and Wegovy, upholding the U.S. Food and Drug Administration's decision to remove the drugs' active ingredient, semaglutide, from the shortage list. "Efforts will continue to make authentic, FDA-approved Wegovy directly available through NovoCare Pharmacy to select telehealth organizations that share our commitment to safe and effective medical treatment for patients," Novo said. Novo's share price fell following the announcement, extending an earlier decline to trade down 6.5% by 1315 GMT. Shares of Hims and Hers fell 22% to $50.02 in U.S. premarket hours.

The Guardian

an hour ago

• The Guardian

Abortions in the US are on the rise three years after Roe v Wade was overturned

Three years after the US supreme court overturned Roe v Wade, erasing the national right to abortion and paving the way for more than a dozen states to ban the procedure, the number of abortions performed in the US is still on the rise – including in some states that ban the procedure. US abortion providers performed 1.14m abortions in 2024, according to new data released Monday by #WeCount, a Society of Family Planning project that has tracked abortion provision since 2022. That's the highest number on record in recent years. 'We were really surprised to see the numbers go up over time,' said Ushma Upadhyay, a University of California, San Francisco professor who serves as co-chair of the #WeCount steering committee. 'Abortion bans haven't really stopped people from needing abortion care. It's just made it harder for them to be able to get them.' Although most of the abortions documented in #WeCount's report took place in person, a growing number of abortions are occurring through telehealth, including among patients living in one of the dozen-plus states that ban virtually all abortions. In a telehealth abortion, patients generally meet virtually with a provider before receiving abortion pills through the mail. By December 2023, 19% of abortions took place through telehealth – but by December 2024, that share had risen to 25%. In the last three months of 2024 alone, more than 70,000 abortions were performed through telehealth. These abortions are particularly popular in states with large rural regions, such as Montana, Nevada and Hawaii. Much of the increase in telehealth abortions can be attributed to the spread of 'shield laws'. Enacted by at least eight states since Roe's fall, these controversial laws are designed to protect abortion providers who treat women in states with bans from prosecution by those states. Demand for shield-law abortions has skyrocketed over the last two years. In July 2023, when the first shield-law abortion providers started operating, they facilitated fewer than 6,000 abortions for people living in states that ban almost all abortions or that restrict telehealth abortions. In December 2024, these providers performed almost 14,000 abortions. 'There's more abortion taking place in Mississippi today than there was prior to Dobbs,' said Dr Angel Foster, a co-founder of the Massachusetts Medication Abortion Access Project (Map), which uses shield laws to ship abortion pills out to about 2,500 patients per month. 'That really speaks to how little access some folks had to in-clinic abortion care prior to Dobbs and how shield law provision and telemedicine has really stepped into that space.' #WeCount also collected information on how many abortions were reported to government authorities in states with abortion bans in 2024. On average, states where abortion is totally banned saw just 30 in-person abortions per month, #WeCount found. All abortion bans permit abortions in emergency situations, but activists have long contended that that bans' exceptions are written so narrowly and vaguely that they are unworkable in practice. Since Roe fell, dozens of women have come forward to say they were denied emergency abortions. In Upadhyay's view, the #WeCount data backs up the claim that exceptions don't work. 'That seems very low,' Upadhyay said. 'That is something that I think states with abortion bans should be paying attention to and be concerned about.' The future of shield laws is now in doubt, as anti-abortion activists are trying to test their durability in court. Texas has sued a New York doctor over accusations that she mailed abortion pills to a woman in Texas, while Louisiana has indicted the same doctor for allegedly mailing a pill to that state. Access to the common abortion drug mifepristone is also under assault. Martin Makary, the FDA commissioner, and Robert F Kennedy Jr, the US health secretary, have called for a 'review' of mifepristone, which is typically used in telehealth abortions – and which has been deemed safe by more than 100 studies conducted across dozens of countries. Kennedy specifically cited the results of a flawed analysis pushed by anti-abortion groups that claimed the complication rates from taking mifepristone are higher than previously known. 'Clearly, it indicates that, at very least, the label should be changed,' Kennedy told the Missouri senator Josh Hawley, a Republican, during a congressional hearing. For now, however, Foster remains optimistic about the future of her work. 'There will be a point where growth stops. There's a finite number of people who have an abortion each year,' Foster said. 'But I do think within our practice and within the shield law space we are anticipating that there will continue to be growth in demand.'